From the understanding of chemical reactions on the molecular level to the knowledge of materials, from product design to the contribution of chemistry to sustainability and innovation
One of the biggest obstacles in green chemical processing and separation processes is the need of specific solvents for each specific process step. The...
The Subject Division Plant based Extracts - Products and Processes of ProcessNet (an initiative of DECHEMA – Society for Chemical Engineering and...
Have you ever wished for smart alternatives to slow experimental progress? Did you find yourself getting tired of repeating experiments many times, one...
In 2016, the 11th Otto Roelen Medal will be awarded for an outstanding achievement in catalysis research. DECHEMA and the German Catalysis Society (GeCatS)...
> Download programme as PDF Enzymes are considered to be little miracle substances for innovation, process advantages and cost...
DECHEMA-Werkstoff-Tabelle (materials charts) - the ultimate reference for corrosion specialists materials scientists...
M4CO2 is a large-scale collaborative research project within the 7th European Framework Programme for Research and Technological Development. The project started January 1, 2014. 16 industrial and academic partners from 8 European countries have formed a consortium combining leading expertise in catalysis, membranes, polymers and reaction engineering.
Das Projekt DaNa2.0 hat zum Ziel, in einem interdisziplinären Ansatz mit Wissenschaftlern aus Humantoxikologie, Ökotoxikologie, Biologie, Physik, Chemie und Pharmazie Forschungsergebnisse zu Nanomaterialien und deren Auswirkungen auf den Menschen und die Umwelt für interessierte Laien verständlich aufzubereiten. Diese Daten werden auf der Internetplattform www.nanopartikel.info und auch durch andere Medien der Öffentlichkeit zugänglich gemacht.
ALEXANDER - Mucus Permeating Nanoparticulate Drug Delivery Systems - was a large-scale collaborative research project within the 7th European Framework Programme for Research and Technological Development. The project ran from April 1, 2012 to March 31, 2016.
Within ALEXANDER, 14 partners from industry and academia have joined forces, combing leading expertise in chemistry, biochemistry, pharmacy, chemical engineering, pharmaceutical technology, molecular physiology, biopharmaceutics, toxicology, drug development and project management.